Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

Michael Hiltzik: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them

Stéphane Bancel, the chief executive of drug company Moderna, could barely restrain his pride in issuing his annual letter to shareholders on Jan. 3.

Los Angeles Times · Jan 24, 2023

FDA lays out annual COVID shot plan similar to flu

Americans will get a clearer idea of how often they’ll roll up their sleeves for COVID-19 shots when advisers to U.S. regulators meet Thursday to discuss an immunization schedule that looks more like the one used for flu.

Tribune News Service · Jan 24, 2023

New mRNA cancer vaccine has a key difference from most jabs

The experimental Moderna melanoma vaccine can't prevent melanoma, but it can be used to treat the cancer.

Inverse · Jan 22, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

‘This will happen before 2030’: how the science behind Covid vaccines might help to fight cancer

The success of mRNA-based drugs in combating coronavirus is inspiring scientists to create similar vaccines for melanoma and other tumours

The Guardian - UK · Jan 22, 2023

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma – a biochemist explains how it works

Media outlets have reported the encouraging findings of clinical trials for a new experimental vaccine developed by the biotech company Moderna to treat an aggressive type of skin cancer called melanoma.

The Conversation · Jan 17, 2023

The US government spent $30bn developing the Covid vaccine. So how can Moderna plan to charge $110 a jab?

Vaccines were built in part on government research and funding, but treatment won’t be free to Americans much longer

The Independent UK · Jan 13, 2023

Bivalent COVID vaccines have now been in use for a few months – here's how they're stacking up against omicron

Vaccines have played a major role in mitigating the harms of the COVID pandemic since their rollout began just over two years ago. They’re estimated to have saved tens of millions of lives around the globe.

The Conversation · Jan 11, 2023

Read news from The Economist, FT, and more,
with one subscription

The 'Kraken' COVID variant taking hold in the U.S. Here's how many vaccine shots there are—and what experts recommend to protect yourself

The highly transmissible 'Kraken' COVID variant is here. Experts say getting boosted is your best protection.

Fortune · Jan 10, 2023

Vaccines are not making COVID strains like 'Kraken' stronger

Scientists say there is no evidence to suggest that vaccinations are making COVID "stronger" and that mutations are a normal part of virus evolution.

Fortune · Jan 9, 2023

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK · Jan 6, 2023

Investing Champion Leif Soreide Notes Biotech Stocks May Be Countercyclical

Biotech stocks can often be countercyclical, according to some market experts. We explore some biotech opportunities in this article.

StockNews.com · Jan 5, 2023

Tory MP condemns colleague's 'nonsense' claims about Covid vaccines

A TORY MP has been accused of spreading “nonsense” about the Covid vaccine by a senior Conservative colleague.

The National (Scotland) · Jan 4, 2023

Covid could help to cure cancer, new research reveals

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

The Independent UK · Jan 2, 2023

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

Tribune News Service · Dec 31, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU · Dec 28, 2022

How a scrappy African startup could forever change the world of vaccines

Afrigen is the linchpin of global project to use mRNA technology to empower low-resource countries to make their own vaccines against killer diseases from TB to HIV. What will it take to succeed?

StockNews.com · Dec 22, 2022

2 Biotech Stock to Buy Over Moderna This December

Biotech giant Moderna (MRNA) missed consensus revenue and EPS estimates in its 2022 third quarter. Moreover, it lost more than 17% in 2022. While analysts are bearish on MRNA’s growth, the industry prospects look bright. Therefore, investors looking to invest in biotech stocks could consider buying Biogen (BIIB) and Jazz…

ABC News · Dec 14, 2022

Moderna mRNA melanoma vaccine may be 'the penicillin moment' in cancer treatment, researchers say

A world-first melanoma vaccine which personalises treatments for patients may put an end to melanoma as a "death sentence", according to Australian experts.

The Independent UK · Dec 14, 2022

Cancer vaccine halves risk of relapse or death using Covid jab technology

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

Get all your
news in one place.

100's of premium titles.
One news app.

The New Daily · Dec 14, 2022

Has Moderna successfully developed a personalised vaccine against melanoma? Maybe

Moderna has partnered with another drug company to produce a personalised vaccine against melanoma for people at risk of dying.

Fortune · Dec 13, 2022

Skin cancer vaccine trial shows promising results

Moderna and Merck team up in new study.

Mic · Dec 13, 2022

Researchers from Moderna and Merck just made a breakthrough with a skin cancer vaccine

Thank you, science.

The Independent UK · Dec 13, 2022

Merck, Moderna detail potential skin cancer vaccine progress

Shares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study

WEKU · Dec 8, 2022

The FDA clears updated COVID-19 vaccines for kids under age 5

The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.

AAP · Dec 7, 2022

Work starts on nation-first mRNA facility

Biotech giant Moderna's first mRNA vaccine facility in Australia is due to open in 2024, and will produce 100 million vaccine doses per year.

Tribune News Service · Dec 6, 2022

The business of clinical trials is booming. Private equity has taken notice

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

1 … 16 17 18 19

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Centers for Disease Control and Prevention

329 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.